Overview
Morningstar has adjusted its fair value estimate for Reece Ltd (ASX:REH) downward by 2% to A$10.30. The firm attributes the cut to its updated assumptions around the weighted average cost of capital (WACC) and the time value of money.
Margins and competitive environment
In its assessment, Morningstar reiterates that Reece benefits from relatively high margins in Australia and New Zealand, a dynamic the firm links to limited competitive pressure in those markets. However, the research house does not expect the business to deliver substantial growth beyond what would come from a cyclical recovery, noting that competition is becoming more focused.
Valuation and margin outlook
Morningstar states that, on the basis of its updated valuation, Reece’s shares appear overvalued. The firm also anticipates that any improvement in the company’s EBITDA margin will be lower than what the current market appears to expect.
Analyst consensus and recent share performance
Data compiled by LSEG show that 14 analysts have an average rating of "hold" on Reece, with a median price target of A$15.45. In the most recent trading session, Reece shares closed at A$16.80. The stock has risen 24.9% year to date.
Key takeaways
- Morningstar reduced its fair value estimate for Reece by 2% to A$10.30, driven by WACC and time-value-of-money assumptions.
- The firm highlights high margins in Australia and New Zealand due to lower competition but does not foresee significant growth beyond cyclical recovery.
- Morningstar views the shares as overvalued and expects less EBITDA margin improvement than the market currently implies.
Risks and uncertainties
- Competition risk - Increasingly focused competitors could limit Reece’s growth prospects and pressure margins.
- Valuation risk - Market pricing is above Morningstar’s revised fair value, exposing investors to downside if margin improvement fails to meet expectations.
Market context
The LSEG consensus of 14 analysts places a median price target at A$15.45, below the current market price, while the stock’s recent close at A$16.80 and year-to-date gain of 24.9% indicate investor optimism that is not shared by Morningstar’s updated valuation.